RxDoctor Payments Data

Hsu Ti Huang

Foot & Ankle Surgery · West Covina, CANPI 1710051404

Payments from drug & device makers

$1,367in general payments, 2019–2025

Across 41 payments — averaging $33.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$500
  • Smith+Nephew$313
  • Bioventus LLC$179
  • Cook Medical LLC$155
  • Cardiovascular Systems Inc.$82
  • Angiodynamics, Inc.$63
  • plus $76 from 4 others

What the payments were for

  • Food & beverage$1,367100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)11$500
Smith+Nephew19$313
Bioventus LLC2$179
Cook Medical LLC2$155
Cardiovascular Systems Inc.1$82
Angiodynamics, Inc.1$63
Melinta Therapeutics, LLC2$30
AbbVie1$20
Venclose Inc.1$14
Merck1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,367 in reported general payments places this provider in the 40th percentile of 1,126 foot & ankle surgery providers in California.

See all foot & ankle surgery providers in California

Medicare billing

Part B allowed, 2024
$126,591
Medicare patients
310
Services billed
1,461

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CiclopiroxCiclopirox Olamine246$6,240
Ammonium Lactate236$4,775
Ciclopirox36$851
Terbinafine Hcl91$616
Doxycycline Hyclate13$446
Diclofenac Sodium24$421
Gabapentin56$287
Meloxicam61$157
Allopurinol60$155
Mupirocin26$117

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in West Covina

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →